Aft Pharms Ltd Drug Patent Portfolio
Aft Pharms Ltd owns 1 orange book drug protected by 3 US patents Given below is the list of Aft Pharms Ltd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11197830 | Pharmaceutical composition containing acetaminophen and ibuprofen | 27 Feb, 2039 | Active |
| US11534407 | Pharmaceutical compostion containing acetominophen and ibuprofen | 27 Feb, 2039 | Active |
| US10532036 | Combination composition | 22 Sep, 2025 | Active |
Latest Legal Activities on Aft Pharms Ltd's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aft Pharms Ltd.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 Jun, 2023 | US10532036 |
| Post Issue Communication - Certificate of Correction | 06 Jun, 2023 | US11534407 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Dec, 2022 | US11534407 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Dec, 2022 | US11534407 |
|
Email Notification
Critical
| 08 Dec, 2022 | US11534407 |
|
Issue Notification Mailed
Critical
| 07 Dec, 2022 | US11534407 |
| Dispatch to FDC | 23 Nov, 2022 | US11534407 |
|
Application Is Considered Ready for Issue
Critical
| 23 Nov, 2022 | US11534407 |
|
Issue Fee Payment Received
Critical
| 18 Nov, 2022 | US11534407 |
|
Issue Fee Payment Verified
Critical
| 18 Nov, 2022 | US11534407 |
| Response to Reasons for Allowance | 18 Nov, 2022 | US11534407 |
| Mailing Corrected Notice of Allowability | 09 Nov, 2022 | US11534407 |
|
Email Notification
Critical
| 09 Nov, 2022 | US11534407 |
| Corrected Notice of Allowability | 03 Nov, 2022 | US11534407 |
|
Information Disclosure Statement considered
Critical
| 03 Nov, 2022 | US11534407 |
Aft Pharms Ltd's Family Patents
Aft Pharms Ltd drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 16.7% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Aft Pharms Ltd Drug List
Given below is the complete list of Aft Pharms Ltd's drugs and the patents protecting them.
1. Combogesic
Combogesic is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11197830 | Pharmaceutical composition containing acetaminophen and ibuprofen |
27 Feb, 2039
(14 years from now)
| Active |
| US11534407 | Pharmaceutical compostion containing acetominophen and ibuprofen |
27 Feb, 2039
(14 years from now)
| Active |
| US10532036 | Combination composition |
22 Sep, 2025
(11 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combogesic's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List